newest glp-1 drugs Eli Lilly to seek approval of new weight-loss drug this year New project announcement: HHS‑OIG is
Description
Vaquero-Abellan, Social Media, Thin-Ideal, Body Dissatisfaction and Disordered Eating Attitudes: An Exploratory Analysis, Int
All medicines carry risks
Paddu, N
So, taking lower doses or titrating more slowly can help
There was no difference in risk for AF between GLP-1RA and SGLT2i
